New muscular disease: Myoglobinopathy
An international collaboration led by IDIBELL identifies the first disease caused by a mutation in myoglobin
New muscular disease: Myoglobinopathy Read More »
An international collaboration led by IDIBELL identifies the first disease caused by a mutation in myoglobin
New muscular disease: Myoglobinopathy Read More »
Innovation is the key to achieve transformation and sustainability in the health system
Collaboration between health institutions and industry creates value for the patient Read More »
Researchers from IDIBELL and ICO show that current mutational analysis techniques are sufficiently sensitive to predict resistance to treatment with EGFR inhibitors in metastatic colorectal cancer
The coordinated activity of PDGFR and CXCR4 signaling pathways in cancer stem cells enhances the development of metastases in advanced skin carcinomas
Scientists unveil the mechanisms that promote metastasis in skin carcinomas Read More »
It has been known for decades that cancer cells have an altered metabolism and it is seen in several biochemical pathways and in particular, in the way they get energy for their survival. If healthy cells use the mitochondrial respiratory chain, tumors use aerobic glycolysis, a process that allows them taking energy quickly but
Researchers find epigenetic loss that changes how cells obtain energy from cancer Read More »
IDIBELL celebrates the second edition of its investors’ day
A study published by Nature Neuroscience shows some people’s brains synchronize the rhythm of the voices they hear, while others do not
Brain’s ability to synchronize voice sounds could be related to language learning Read More »